BQ interaction (link):
- CAPEX of 150 cr. for 4 new specialty chemical products (brownfield products; forward integration of butyl phenol products; niche products meant for exports; ROI ~ 20%); should be finished by Q1FY22; capacity utilization will be ~50% by FY22 and will go up to 90% by FY23-24
- Most of supplies come from Indian companies
- IBB demand which was very strong in Q1 has normalized to normal levels
- ATBS demand is slow currently
- Butyl phenol plant ready and currently making 3 out of 4 products
- Q2 and Q3 will see effects of pandemic induced slowdown on revenues
- Wants to double revenue in 3-4 years (targeting 15-20% growth)